Bojana Jovanovic

4PUBLICATIONS
61CO-AUTHORS
Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 05, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.

Shom Goel, Bojana Jovanović, Xiangying Chu

|Aug 13, 2024
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies.

Bojana Jovanović, Sarah E Church, Kara M Gorman

|Nov 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.

Laura E Stevens, Guillermo Peluffo, Xintao Qiu

|Jul 25, 2020
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition.

Anne Fassl, Christopher Brain, Monther Abu-Remaileh

Pageof 1